U.K.-based drug giant AstraZeneca will make what it calls its single-largest manufacturing investment in the world with a new facility in Virginia.
The company has not identified the site in Virginia where it plans to build the facility, but said it will be a multi-billion-dollar project. The facility will produce drugs for its weight management and metabolic portfolio of existing and developing treatments.
AstraZeneca said the Virginia facility will leverage artificial intelligence, automation and data analytics to optimize production.
The Virginia announcement is part of a larger $50 billion commitment to expanding manufacturing and research and development in the U.S. by 2030, including expansions of its existing facilities in Rockville and Gaithersburg, Maryland.
Click here to read the rest of the article written by Jeff Clabaugh over at WTOP
